Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma

Melania Carlisi,R. Lo Presti,F. Plano,S. Mancuso,S. Siragusa,G. Caimi

DOI: https://doi.org/10.1038/s41598-024-53385-6

IF: 4.6

2024-02-04

Scientific Reports

Abstract:RDW is an erythrocyte index that increase in multiple myeloma, in which it appears to have an important role in predicting outcome. For this reason, we performed a retrospective analysis to evaluate the relationships of RDW with some important prognostic predictors. Specifically, in a cohort of 190 newly diagnosed multiple myeloma patients, we have examined the behaviour of RDW and its trend in relation to the ISS stage and other prognostic factors, such as albumin, beta-2 microglobulin, LDH and bone marrow plasma cell infiltration. We performed the analysis in the entire cohort of patients and in the three different disease isotypes (Light chain, IgA, and IgG multiple myeloma). The evaluation of RDW in the different isotypes was made with the Kruskal–Wallis test, integrated by the Dunn test. The comparison between the subgroups allocated above and below the median value of each prognostic factor, was made with the Mann–Whitney test. From our analysis, we observed that RDW is higher in the IgA multiple myeloma, and it increases significantly from ISS I to III. Moreover, RDW increases in the presence of lower albumin values, higher levels of beta2-microglobulin and LDH and in the presence of a greater bone marrow plasma cell infiltrate.

multidisciplinary sciences

What problem does this paper attempt to address?

The paper attempts to address the issue of evaluating the changes in Red Cell Distribution Width (RDW) in newly diagnosed multiple myeloma (MM) patients and its relationship with prognostic predictors. Specifically, the researchers aim to explore the behavior trends of RDW in different International Staging System (ISS) stages and other important prognostic factors (such as albumin, β2-microglobulin, lactate dehydrogenase (LDH), and bone marrow plasma cell infiltration) through a retrospective analysis.

### Main Research Questions:
1. **Changes in RDW in different MM subtypes**: The researchers aim to understand the differences in RDW among light chain, IgA, and IgG types of multiple myeloma.
2. **Relationship between RDW and ISS staging**: The researchers aim to evaluate the trend of RDW changes from ISS stage I to III.
3. **Relationship between RDW and other prognostic factors**: The researchers aim to explore the relationship between RDW and prognostic factors such as albumin, β2-microglobulin, LDH, and bone marrow plasma cell infiltration.

### Research Background:
- **Significance of RDW**: RDW is a dimensionless quantitative parameter that represents the standard deviation of red blood cell volume divided by the mean volume, reflecting the degree of variation in cell size within the red blood cell population.
- **Role of RDW in MM**: Previous studies have shown that RDW increases in multiple myeloma and is associated with disease progression and poor prognosis.
- **Prognostic Factors**: Albumin, β2-microglobulin, LDH, and bone marrow plasma cell infiltration are important prognostic predictors in multiple myeloma.

### Research Methods:
- **Study Design**: Single-center retrospective analysis.
- **Study Subjects**: 190 newly diagnosed multiple myeloma patients.
- **Data Collection**: Parameters such as RDW, albumin, β2-microglobulin, LDH, and bone marrow plasma cell infiltration were obtained from the baseline laboratory test results of the patients.
- **Statistical Analysis**: Statistical analysis was performed using GraphPad Prism 9.5, with data presented as medians and interquartile ranges. Group comparisons were made using the Kruskal-Wallis test and Dunn's test.

Through these analyses, the researchers hope to provide more information for the prognostic assessment of multiple myeloma patients, particularly the potential value of RDW as a prognostic indicator.